Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 43 (1), 147-55, xi

Pharmacologic Management of Cough


Pharmacologic Management of Cough

Donald C Bolser. Otolaryngol Clin North Am.


This review is an update of recent advances in our understanding of cough suppressants and impairment of cough. Low-dose oral morphine has recently been shown to significantly suppress chronic cough, but the side effect profile of this opioid may limit its widespread utility. Several studies have demonstrated a dissociation between the efficacy of antitussives in some metrics of pathologic cough and their effects on cough sensitivity to inhaled irritants. The relevance of widely used inhaled irritants in understanding pathologic cough and its response to antitussives is questionable. A recent advance in the field is the identification and measurement of an index of sensation related to cough: the urge to cough. This measure highlights the potential involvement of suprapontine regions of the brain in the genesis and potential suppression of cough in the awake human. There are no new studies showing that mucolytic agents are of value as monotherapies for chronic cough. However, some of these drugs, presumably because of their antioxidant activity, may be of use as adjunct therapies or in selected patient populations. The term dystussia (impairment of cough) has been coined recently and represents a common and life-threatening problem in patients with neurologic disease. Dystussia is strongly associated with severe dysphagia and the occurrence of both indicates that the patient has a high risk for aspiration. No pharmacologic treatments ae available for dystussia, but scientists and clinicians with experience in studying chronic cough are well qualified to develop methodologies to address the problem of impaired cough.

Similar articles

  • Currently Available Antitussives
    PV Dicpinigaitis. Pulm Pharmacol Ther 22 (2), 148-51. PMID 18771744. - Review
    Cough is among the most common complaints for which patients seek medical attention. Acute cough, usually due to a viral upper respiratory tract infection, generates a hu …
  • [Antitussives and Expectorants]
    K Sander et al. Pharm Unserer Zeit 37 (6), 462-71. PMID 18956360. - Review
  • Clinical Cough VI: The Need for New Therapies for Cough: Disease-Specific and Symptom-Related Antitussives
    KF Chung. Handb Exp Pharmacol (187), 343-68. PMID 18825350. - Review
    Cough is a common symptom that can be self-limiting or persistent. Ideally, treatment of the underlying cause(s) of cough with specific treatments should eliminate cough. …
  • Chronic Cough
    B Wee. Curr Opin Support Palliat Care 2 (2), 105-9. PMID 18685405. - Review
    The availability of simple assessment tools places the imperative on clinicians to be more systematic in assessment of cough and its interventions. The mainstay of oral t …
  • Currently Available Cough Suppressants for Chronic Cough
    KF Chung. Lung 186 Suppl 1, S82-7. PMID 17909897. - Review
    Chronic cough is a common symptom but only a fraction of patients seek medical attention. Addressing the causes of chronic cough may lead to control of cough; however, th …
See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

Publication types